STRYKER CORP SYK 75.68
Health Care · NYSE · Data as of 2026-10-30
STRYKER CORP (SYK) has delivered +9.0% annualized revenue growth, +8.6% earnings growth, and +9.7% dividend growth over 10 years of data. Ranked #166 of 1968 stocks overall and #14 of 260 in the Health Care sector by Steady Score.
About STRYKER CORP
Company Overview
Stryker develops and sells medical technologies used in surgery, hospital care and emergency medicine. Its portfolio includes orthopedic implants, surgical instruments, navigation systems, endoscopy equipment, patient-handling products, emergency devices and technologies for treating neurological and vascular conditions. Hospitals, surgeons and other healthcare providers use these products to support joint replacement, trauma care, minimally invasive procedures and patient transport around the world.
Read more
Business Model & Revenue
Stryker earns revenue mainly from sales of implants, disposable products, capital equipment and related service. Implant and consumable demand follows procedure volumes, while equipment sales depend on hospital budgets and replacement cycles; maintenance and service add continuing revenue. The company reports MedSurg and Neurotechnology as one segment and Orthopaedics as another. Direct sales representatives and specialized support teams work closely with healthcare customers.
Key Facts & Market Position
The portfolio spans both recurring procedure-related products and durable hospital equipment, giving Stryker exposure to multiple clinical departments. Orthopaedics includes joint replacement, trauma and spine offerings, while the other segment covers surgical, medical, neurotechnology and vascular products. Medical-device regulation, surgeon training, product quality and evidence supporting clinical use are central to its market position.